leucovorin

(redirected from Leucovorin calcium)
Also found in: Dictionary, Medical.

leucovorin

[lü′käv·ə·rən]
(pharmacology)
Folinic acid used as a calcium salt to counteract the toxic effects of folic acid antagonists and for treatment of megaloblastic anemias.
References in periodicals archive ?
Leucovorin Calcium is also used as a rescue drug after high-dose methotrexate therapy in osteosarcoma, in the treatment of megaloblastic anemia due to folic acid deficiency when oral therapy is not feasible, and in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer.
(111) See Current Drug Shortages L-N: Leucovorin Calcium Lyophilized Powder for Injection, U.S.
Pharmaceutical company Sagent Pharmaceuticals Inc (NasdaqGM:SGNT) said on Monday that it has introduced Leucovorin Calcium for Injection in four latex-free and preservative-free vial presentations.
Speciality most frequently Drug Name billing for drug Average AWP * Docetaxel oncology $313.51 Irinotecan oncology $141.32 Leucovorin calcium oncology $18.44 Ondansetron HCI, injection oncology $6.41 Average Widely available discount from AWP Drug Name (Percentage) ** Docetaxel 22.0 Irinotecan 22.9 Leucovorin calcium 85.6 Ondansetron HCI, injection 12.8 * Average of the average wholesale price of each National Drug Code for that product adjusted to the dosage defined by the Health Care Financing Administration common procedure coding system.
Hikma Pharmaceuticals PLC (Hikma), (rated Ba1 Moodys / BB+ S&P, both stable), the fast growing multinational pharmaceutical group, announces that its supplemental Abbreviated New Drug Application (sANDA) for Leucovorin Calcium Injection, 350 mg Single-use vial has been approved by the U.S.
M2 PHARMA-October 30, 2012-Sagent Pharmaceuticals Inc unveils Leucovorin Calcium for Injection(C)2012 M2 COMMUNICATIONS